Labcorp Holdings Cost of Goods Sold 2010-2025 | LH
Labcorp Holdings annual/quarterly cost of goods sold history and growth rate from 2010 to 2025. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Labcorp Holdings cost of goods sold for the quarter ending March 31, 2025 was $2.397B, a 5.17% increase year-over-year.
- Labcorp Holdings cost of goods sold for the twelve months ending March 31, 2025 was $9.502B, a 6.91% increase year-over-year.
- Labcorp Holdings annual cost of goods sold for 2024 was $9.385B, a 6.68% increase from 2023.
- Labcorp Holdings annual cost of goods sold for 2023 was $8.797B, a 7.87% increase from 2022.
- Labcorp Holdings annual cost of goods sold for 2022 was $8.155B, a 0.14% increase from 2021.
| Labcorp Holdings Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024 | $9,385 |
| 2023 | $8,797 |
| 2022 | $8,155 |
| 2021 | $8,144 |
| 2020 | $9,026 |
| 2019 | $8,302 |
| 2018 | $8,157 |
| 2017 | $7,216 |
| 2016 | $6,699 |
| 2015 | $5,777 |
| 2014 | $3,809 |
| 2013 | $3,585 |
| 2012 | $3,422 |
| 2011 | $3,268 |
| 2010 | $2,906 |
| 2009 | $2,724 |
| Labcorp Holdings Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2025-03-31 | $2,397 |
| 2024-12-31 | $2,433 |
| 2024-09-30 | $2,378 |
| 2024-06-30 | $2,295 |
| 2024-03-31 | $2,279 |
| 2023-12-31 | $2,212 |
| 2023-09-30 | $2,206 |
| 2023-06-30 | $2,192 |
| 2023-03-31 | $2,188 |
| 2022-12-31 | $1,527 |
| 2022-09-30 | $1,981 |
| 2022-06-30 | $1,981 |
| 2022-03-31 | $2,667 |
| 2021-12-31 | $328 |
| 2021-09-30 | $2,677 |
| 2021-06-30 | $2,576 |
| 2021-03-31 | $2,563 |
| 2020-12-31 | $2,585 |
| 2020-09-30 | $2,337 |
| 2020-06-30 | $2,008 |
| 2020-03-31 | $2,096 |
| 2019-12-31 | $2,133 |
| 2019-09-30 | $2,111 |
| 2019-06-30 | $2,057 |
| 2019-03-31 | $2,002 |
| 2018-12-31 | $2,015 |
| 2018-09-30 | $2,041 |
| 2018-06-30 | $2,031 |
| 2018-03-31 | $2,069 |
| 2017-12-31 | $1,928 |
| 2017-09-30 | $1,837 |
| 2017-06-30 | $1,750 |
| 2017-03-31 | $1,701 |
| 2016-12-31 | $1,878 |
| 2016-09-30 | $1,626 |
| 2016-06-30 | $1,604 |
| 2016-03-31 | $1,591 |
| 2015-12-31 | $1,560 |
| 2015-09-30 | $1,552 |
| 2015-06-30 | $1,496 |
| 2015-03-31 | $1,168 |
| 2014-12-31 | $966 |
| 2014-09-30 | $981 |
| 2014-06-30 | $948 |
| 2014-03-31 | $914 |
| 2013-12-31 | $911 |
| 2013-09-30 | $915 |
| 2013-06-30 | $891 |
| 2013-03-31 | $869 |
| 2012-12-31 | $867 |
| 2012-09-30 | $863 |
| 2012-06-30 | $844 |
| 2012-03-31 | $847 |
| 2011-12-31 | $817 |
| 2011-09-30 | $836 |
| 2011-06-30 | $815 |
| 2011-03-31 | $800 |
| 2010-12-31 | $766 |
| 2010-09-30 | $749 |
| 2010-06-30 | $705 |
| 2010-03-31 | $687 |
| 2009-12-31 | $689 |
| 2009-09-30 | $687 |
| 2009-06-30 | $681 |
| 2009-03-31 | $666 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $21.919B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.316B | 26.95 |
| CVS Health (CVS) | United States | $75.446B | 9.38 |
| Elevance Health (ELV) | United States | $64.396B | 8.66 |
| Cencora (COR) | United States | $55.472B | 19.30 |
| DiDi Global (DIDIY) | China | $25.980B | 27.60 |
| Natera (NTRA) | United States | $18.843B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| ICON (ICLR) | Ireland | $15.316B | 14.74 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.929B | 0.00 |
| CochLear (CHEOY) | Australia | $13.403B | 0.00 |
| Solventum (SOLV) | United States | $12.763B | 13.51 |
| Medpace Holdings (MEDP) | United States | $12.728B | 33.68 |
| Revvity (RVTY) | United States | $11.202B | 19.44 |
| Viatris (VTRS) | United States | $10.868B | 3.73 |
| Avantor (AVTR) | United States | $9.533B | 13.85 |
| Sonic Healthcare (SKHHY) | Australia | $9.208B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.791B | 17.23 |
| HealthEquity (HQY) | United States | $8.281B | 36.27 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.884B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.109B | 30.08 |
| BrightSpring Health Services (BTSG) | United States | $3.600B | 33.03 |
| Sotera Health (SHC) | United States | $3.489B | 19.82 |
| Surgery Partners (SGRY) | United States | $2.876B | 37.40 |
| Organon (OGN) | United States | $2.592B | 2.75 |
| Concentras Parent (CON) | United States | $2.576B | 14.89 |
| GeneDx Holdings (WGS) | United States | $2.423B | 93.31 |
| Alignment Healthcare (ALHC) | United States | $2.346B | 0.00 |
| Progyny (PGNY) | United States | $1.989B | 43.77 |
| PACS (PACS) | United States | $1.792B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.789B | 35.79 |
| Premier (PINC) | United States | $1.739B | 13.20 |
| Ardent Health (ARDT) | United States | $1.525B | 6.50 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.228B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.088B | 8.28 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.824B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.753B | 7.05 |
| CareDx (CDNA) | United States | $0.712B | 11.12 |
| Embecta (EMBC) | United States | $0.662B | 4.46 |
| Nutex Health (NUTX) | United States | $0.513B | 7.77 |
| So-Young (SY) | China | $0.513B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.506B | 0.00 |
| LifeMD (LFMD) | United States | $0.494B | 0.00 |
| Omada Health (OMDA) | $0.478B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.477B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 10.28 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.406B | 0.00 |
| Enhabit (EHAB) | United States | $0.344B | 28.29 |
| Oncology Institute (TOI) | United States | $0.336B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.286B | 0.00 |
| Beauty Health (SKIN) | United States | $0.222B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.204B | 0.00 |
| DocGo (DCGO) | United States | $0.152B | 24.83 |
| Sera Prognostics (SERA) | United States | $0.118B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| KindlyMD (NAKA) | United States | $0.077B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |